Improving Biomarker Discovery and Development in Urothelial Carcinoma
Petros Grivas, MD, PhD, discusses the challenge with biomarker discovery currently in the treatment landscape of urothelial carcinoma.
Expert Highlights Next Steps to Evolve the Treatment Landscape of Urothelial Cancer
Peter Grivas, MD, PhD, discusses the next steps necessary for the treatment landscape of advanced urothelial cancer to evolve.